Treatment of primary Sjögren's syndrome with D-penicillamine: A pilot study

Netherlands Journal of Medicine

Volumn 60, Issue 10, 2002, Pages 402-406

  ter Borg, E J ^a   Haanen, H C M ^a   Haas, F J L M ^a   Bistervels, J H G M ^a   Huisman, F W ^a   Kerckhaert, J A ^b   Kallenberg, C G M ^c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b EEMLAND HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PENICILLAMINE; PREDNISOLONE; ANTIRHEUMATIC AGENT;

ADULT; AGED; ANOREXIA; ARTICLE; CHEILITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATITIS; DIPLOPIA; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG MECHANISM; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOLOGIC DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOLOGICAL PARAMETERS; MALAISE; MALE; NAUSEA; PAROTID GLAND; PATIENT CARE; PATIENT SATISFACTION; PROSPECTIVE STUDY; PROTEINURIA; SALIVATION; SCHIRMER TEST; SJOEGREN SYNDROME; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; TASTE DISORDER; COMPARATIVE STUDY; DRUG SCREENING; METABOLISM; MIDDLE AGED; NETHERLANDS; PILOT STUDY;

ADULT; AGED; ANTIRHEUMATIC AGENTS; DRUG EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PENICILLAMINE; PILOT PROJECTS; SJOGREN'S SYNDROME;

EID: 0036878495     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kruize AA, Hene RJ, Kallenberg CGM, et al. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 1993:52:360-4.
2. Drosos AA, Skopouli FN, Costopoulos JS, et al. Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study. Ann Rheum Dis 1986;45:732-5.
3. Skopouli FN, Jagiello P, Tsifetaki N, et al. Methotrexate in primary Sjögren's syndrome. Clin Exp Rheumatol 1996;14:555-8.
4. Price EJ, Rigby SP, Clancy U, et al. A double blind placebo controlled trial of azathioprine in the treatment of primary Sjö gren's syndrome. J Rheumatol 1998;25:896-9.
5. 4. J Clin Invest 1980; 65:1069-76.
6. Lipsky PE. Mechanisms of action of D-penicillamine in rheumatoid arthritis. Adv Inflamm Res 1984;7:175-84.
7. Wernick R, Merryman P, Jaffe I, et al. IgG and IgM rheumatoid factors in rheumatoid arthritis. Arthritis Rheum 1983;26:593-8.
8. Olsen N, Ziff M, Jasin HE. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine. J Rheumatol 1984;11:17-21.
9. Zuckner J, Ramsey RH, Dorner RW, et al. D-penicillamine 4 rheumatoid arthritis. Arthritis Rheum 1970;13:131-8.
10. Jaffe IA. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Arthritis Rheum 1965;8:1064-79.
11. Bodeutsch C, Wilde PCM de, Kater L, et al. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome. Arthritis Rheum 1992;35:1075-87.
12. Wilde PCM de, Kater L, Baak JBA, et al. A new and highly specific sensitive immunohistologic diagnostic criterion for Sjö gren's syndrome. Arthritis Rheum 1989;32:1214-20.
13. Anderson LG, Cummings NA, Asofsky R, et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögrens's syndrome. Natural history and response to treatment. Am J Med 1972; 53:456-63.
14. Horsfall AC, Rose LM, Maini RN. Autoantibody synthesis in salivary glands of Sjögrens syndrome patients. J Autoimmun 1989;2:559-68.
15. Atkinson JC, Travis WD, Slocum L, et al. Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. Arthritis Rheum 1992;35:1368-72.
16. LakHanPal S, Duffy J, Griffing WL, et al. Sjögren's syndrome: treatment with D-penicillamine and hydroxychloroquine. J Rheumatol 1985;12:1028-9.
17. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for he classification of Sjögrens syndrome. Arthritis Rheum 1993;36:340-7.
18. Leeuwen MA van, Westra J, Riel PL van, et al. IgM, IgA and IgG Rheumatoid factors in early rheumatoid arthritis. Predictive of radiological progression? Scand J Rheumatol 1995;24:146-53.
19. Talal N, Asofsky R, Lightbody P. Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest 1970;49:49-54.